Search Results
Site Search
Learn how reliable laboratory diagnosis of a platelet disorders can impact patients’ and their family members' clinical management and outcomes.
Mayo Clinic Laboratory and Pathology Research Roundup: March 5 - Insights
This week's research roundup feature: Variants of uncertain significance (VUSs) in BRCA2 are a common result of hereditary cancer genetic testing. While more than 4,000 unique VUSs, comprised of missense or intronic variants, have been...
Manage to Reimbursement - Insights
PACE/State of FL - This webinar will provide a methodology for laboratory leadership to review their test menu for assays that most impact the financial health of their laboratory.
Autoimmune Profile Updates [Test in Focus] - Insights
Andrew McKeon, M.B., B.Ch., M.D., discusses updates that are being made to Mayo Clinic Laboratories' autoimmune profile that will remove some antibodies from those profiles. He describes the rationale behind the updates, reviews which...
Mayo Clinic Laboratories’ pharmacogenomic testing offers superior analytical quality, enabling targeted detection of more clinically actionable alleles than other testing.
CPT Codes and LOINC Update: Feb. 2019 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of February 2019.
CPT codes and LOINC update: November 2022 - Insights
This list includes updates posted to mayocliniclabs.com during the month of November.
HOPE Experience Essentials in Phlebotomy - Insights
Phlebotomists play a critical role in shaping a patient’s experience — from the first interaction to the last reassuring word. The HOPE Experience Essentials: Creating Moments That Matter program is designed to inspire and empower...
Mayo Clinic Laboratory and Pathology Research Roundup: March 2 - Insights
This week’s Research Roundup highlights high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.
Mayo Clinic Laboratory and pathology research roundup: September 19 - Insights
This week's research roundup feature: There is a need to develop safe and effective pharmacologic options for the treatment of celiac disease (CeD); however, consensus on the appropriate design and configuration of randomized controlled...
Mayo Clinic Laboratory and Pathology Research Roundup: October 17 - Insights
This week's research roundup feature: Given the prevalence of dementia and the development of pathology-specific disease modifying therapies, high-value biomarker strategies to inform medical decision making are critical. In-vivo tau...
Mayo Clinic Laboratory and Pathology Research Roundup: November 28 - Insights
This week's research roundup feature: Microaggressions between members of a team occur often in medicine, even despite good intentions. Such situations call for difficult conversations that restore inclusivity, diversity, and a healthy work...
Complement Testing in the Diagnosis and Management of Thrombotic Microangiopathy - Insights
PACE / State of FLThis month’s “Virtual Lecture” discusses the clinical diagnosis and management, summarizes the testing modalities that guide diagnosis and management, and recognizes the utility of genetic testing as it relates to...
Mayo Clinic Laboratory and pathology research roundup: June 27 - Insights
This week's research roundup feature: SARS-CoV-2 spike codon mutations and risk of hospitalization after antispike monoclonal antibody therapy in solid organ transplant recipients.
Mayo Clinic Laboratory and pathology research roundup: July 18 - Insights
This week's research roundup feature: Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
Mayo Clinic Laboratory and pathology research roundup: August 1 - Insights
This week's research roundup feature: A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling.
Mayo Clinic Laboratories vector-borne disease testing is guided by an algorithm approach that supports the right test in the right region. Our comprehensive suite of vector-borne disease tests includes testing for the most commonly...
Learn about our hereditary cancer test offerings, including single-gene assays that evaluate specific genes already identified in a parent.
Check out Mayo Clinic Laboratories’ expert-developed biochemical and molecular testing to confirm a diagnosis of oligosaccharidosis.
HOPE Experience Essentials in Phlebotomy - Insights
Phlebotomists play a critical role in shaping a patient’s experience — from the first interaction to the last reassuring word. The HOPE Experience Essentials: Creating Moments That Matter program is designed to inspire and empower...
HOPE Experience Essentials in Phlebotomy - Insights
Phlebotomists play a critical role in shaping a patient’s experience — from the first interaction to the last reassuring word. The HOPE Experience Essentials: Creating Moments That Matter program is designed to inspire and empower...
HOPE Experience Essentials in Phlebotomy - Insights
Phlebotomists play a critical role in shaping a patient’s experience — from the first interaction to the last reassuring word. The HOPE Experience Essentials: Creating Moments That Matter program is designed to inspire and empower...
Lung Cancer Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories innovates at the speed of medical advancement, and offers comprehensive options for diagnostic, prognostic, and predictive lung cancer testing.
CPT codes and LOINC update: August 2024 - Insights
This page lists updates posted to Mayo Clinic Labs during the month of August.
Rapid hereditary breast cancer - Insights
Learn how our rapid breast cancer treatment panel delivers results in 10 to 14 days and detects 11 genes linked to lifetime breast cancer risk.
CPT codes and LOINC update: May 2024 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of May.
Axonal autoimmune neuropathies - Insights
Find out about our panel-based approach to axonal autoimmune neuropathies, which we recommend because of the overlap in clinical symptoms.
HOPE Experience Essentials in Phlebotomy - Insights
Phlebotomists play a critical role in shaping a patient’s experience — from the first interaction to the last reassuring word. The HOPE Experience Essentials: Creating Moments That Matter program is designed to inspire and empower...
HOPE Experience Essentials in Phlebotomy - Insights
Phlebotomists play a critical role in shaping a patient’s experience — from the first interaction to the last reassuring word. The HOPE Experience Essentials: Creating Moments That Matter program is designed to inspire and empower...
HOPE Experience Essentials in Phlebotomy - Insights
Phlebotomists play a critical role in shaping a patient’s experience — from the first interaction to the last reassuring word. The HOPE Experience Essentials: Creating Moments That Matter program is designed to inspire and empower...
Histiocytic neoplasms - Insights
Learn more about how Mayo Clinic Laboratories’ next-generation sequencing panel for histiocytic neoplasms can help physicians accurately diagnose patients and guide treatment for their patients.
PACE/State of FL - This "Phlebotomy Webinar" will review proper blood culture collection techniques and demonstrate how specimen quality can impact patient care.
Contact Us - Mayo Clinic Laboratories
Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...
Mayo Clinic Laboratory and Pathology Research Roundup: June 18 - Insights
This week’s Research Roundup features highly discriminant methylated DNA markers for the non-endoscopic detection of Barrett's esophagus.
Mayo Clinic Laboratory and Pathology Research Roundup: July 9 - Insights
This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.
Mayo Clinic Laboratory and Pathology Research Roundup: May 21 - Insights
This week’s Research Roundup highlights the development and validation of a prostate cancer genomic signature that predicts early androgen deprivation therapy (ADT) treatment response following radical prostatectomy.
Mayo Clinic Laboratory and Pathology Research Roundup: Jan. 28 - Insights
This week’s Research Roundup highlights the diagnostic accuracy of echocardiography and intraoperative surgical inspection of the unicuspid aortic valve.
Joseph Maleszewski, M.D., on Gene Testing in Cardiomyopathy Analysis in CAP Today - Insights
At the annual meeting of the Association for Molecular Pathology this past November, Joseph Maleszewski, M.D., a cardiovascular pathologist and Professor of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, presented...
Allan Jaffe, M.D., Discusses Use of Highly Sensitive Cardiac Troponin in CAP Today - Insights
Allan Jaffe, M.D., Consultant and Chair of Mayo Clinic’s Division of Clinical Core Laboratory Services, with a joint appointment in the Division of Cardiovascular Diseases, spoke with CAP Today about what a new higher-sensitivity cardiac...
Mayo Clinic Laboratory and Pathology Research Roundup: March 6 - Insights
This week’s Research Roundup highlights outcomes of warfarin therapy for bioprosthetic valve thrombosis of surgically implanted valves.
Contact Us - Mayo Clinic Laboratories
Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...
Learn why liquid biopsy testing is a viable alternative to tissue-based biopsy testing for certain patients with cancer.
Learn about our sponsored testing program and how it can benefit both patients and healthcare providers.
New tests launched in April - Insights
In April 2022, Mayo Clinic Laboratories announced fourteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Chronic lymphocytic leukemia - Insights
Learn how we increase the quality of care by performing all of our chronic lymphocytic leukemia testing at a single facility.
Malabsorption disorders - Insights
Malabsorption syndrome encompasses several disorders that impact the ability of the small intestine to absorb macronutrients, micronutrients, or both. Because malabsorption syndrome can be caused by myriad factors, identifying the...
Online education and training provided through pre-recorded presentations and interactive learning modules.
Mayo Clinic Laboratories’ fungal diagnostics test menu includes molecular and serological assays to aid in diagnosing a wide variety of fungal diseases, including those caused by Coccidioides possadasi/immitis, Histoplasma, Blastomyces, and...
Lab Billing, Coding, and Compliance: A 2025 Overview - Insights
PACE/State of FL - Critical topics essential for laboratory billing, coding, and compliance.
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D. - Insights
Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and...